Results 171 to 180 of about 2,636,203 (317)

Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure. [PDF]

Commun Med (Lond)
Hsu WH, Shiau BW, Wu JY, Chuang MH, Tsai YW, Huang PY, Hu KC, Hsu W, Liu TH, Liao KM, Lai CC.   +10 more
europepmc   +1 more source

The Docking of Arg2 of Angiotensin II with Asp281 of AT1 Receptor Is Essential for Full Agonism [PDF]

, 1995
Ying-Hong Feng, Keita Noda, Yasser Saad, Xiao-pu Liu, Ahsan Husain, Sadashiva S. Karnik   +5 more
openalex   +1 more source

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

Circulation, 2016
Scott A. Hubers, N. Brown
semanticscholar   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Use of Angiotensin Receptor Blockers in Celiac Disease Associated with Worse Outcomes. [PDF]

Dig Dis Sci
Hujoel IA, Hujoel MLA.
europepmc   +1 more source

Suppression of Resting Metabolism by the Angiotensin AT2 Receptor [PDF]

, 2016
Nicole K. Littlejohn, Henry L. Keen, Benjamin J. Weidemann, Kristin E. Claflin, Kevin V. Tobin, Kathleen R. Markan, Sungmi Park, Meghan C. Naber, Françoise A. Gourronc, Nicole A Pearson, Xuebo Liu, Donald A. Morgan, Aloysius J. Klingelhutz, Matthew J. Potthoff, Kamal Rahmouni, Curt D. Sigmund, Justin L. Grobe   +16 more
openalex   +1 more source

Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction. [PDF]

Eur Heart J Cardiovasc Pharmacother
Humphreys ABC, Lindahl B, Berglund A, Voelskow V, Fang S, Fröbert O, Hofmann R, Jernberg T, Hernán MA, Matthews AA.   +9 more
europepmc   +1 more source

LCZ696, an angiotensin receptor–neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin‐induced diabetic mice

European Journal of Heart Failure, 2016
Yasunori Suematsu, S. Miura, Masaki Goto, Yoshino Matsuo, Tadaaki Arimura, T. Kuwano, S. Imaizumi, A. Iwata, E. Yahiro, K. Saku   +9 more
semanticscholar   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathogenesis of preeclampsia

Jing Wang, Shan Lang, Yanhui Zhao, Hongwen Cao, Shuhai Lan, Yizhong Yan   +5 more
openalex   +1 more source